Search filters

List of works by Yasuharu Shinoda

Acyl‐CoA binding domain containing 3 (ACBD3) recruits the protein phosphatase PPM1L to ER–Golgi membrane contact sites

scientific article published on July 10, 2012

Alzheimer's disease therapeutic candidate SAK3 is an enhancer of T-type calcium channels

scientific article published on 18 December 2018

An α-synuclein decoy peptide prevents cytotoxic α-synuclein aggregation caused by fatty acid binding protein 3

scientific article published on 01 January 2021

Anti-Epileptic Effects of FABP3 Ligand MF1 through the Benzodiazepine Recognition Site of the GABAA Receptor

scientific article published on 01 August 2020

Combined Memantine and Donepezil Treatment Improves Behavioral and Psychological Symptoms of Dementia-Like Behaviors in Olfactory Bulbectomized Mice

scientific article published on 4 January 2017

Combined citicoline and docosahexaenoic acid treatment improves cognitive dysfunction following transient brain ischemia

scientific article published on 20 February 2019

Corticosteroids Mediate Heart Failure-Induced Depression through Reduced σ1-Receptor Expression

scientific article

Crucial Role of Dopamine D2 Receptor Signaling in Nicotine-Induced Conditioned Place Preference

scientific article published on 25 May 2019

Development of FABP3 ligands that inhibit arachidonic acid-induced α-synuclein oligomerization

scientific article published on 26 November 2018

Haloperidol aggravates transverse aortic constriction-induced heart failure via mitochondrial dysfunction

scientific article published on 4 June 2016

Inhibition of Nicotine Dependence by Curcuminoid Is Associated with Reduced Acetylcholinesterase Activity in the Mouse Brain

scientific article published on 10 August 2018

KY-226 Protects Blood-brain Barrier Function Through the Akt/FoxO1 Signaling Pathway in Brain Ischemia

scientific article published on 21 December 2018

Ouabagenin is a naturally occurring LXR ligand without causing hepatic steatosis as a side effect

scientific article

SAK3 Administration Improves Spine Abnormalities and Cognitive Deficits in AppNL-G-F/NL-G-F Knock-in Mice by Increasing Proteasome Activity through CaMKII/Rpt6 Signaling

scientific article published on 28 May 2020

Targeted disruption of the mouse protein phosphatase ppm1l gene leads to structural abnormalities in the brain

scientific article published on 22 September 2016

Wildtype sigma-1 receptor and the receptor agonist improve ALS-associated mutation-induced insolubility and toxicity

scientific article published on 14 October 2020